Skip to main content

PBYI Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Puma Biotechnology Inc News

Nektar Shares Drop After Double Downgrade to Sell at Goldman Sachs

Goldman also slashes its one-year price target by nearly two-thirds on expectations that Nektar's in-the-works cancer treatment won't generate revenue anytime soon.

Hold on Tight: Cramer's 'Mad Money' Recap

Fasten your seatbelt, says Jim Cramer. Trade tensions are making for a wild ride on Wall Street, but stocks are almost in oversold territory.

Disney, 21st Century Fox, Village Farms: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Disney, 21st Century Fox, Village Farms, SailPoint Technologies, Magellan Midstream Partners, Becton Dickinson, Puma Biotechnology, Parsons and more.

Puma Biotech Plunges on Sharp Drop in Cancer-Drug Sales

Shares of Puma Biotechnology plunge after the company reveals that more patients than expected have discontinued treatment with its breast cancer drug, Nerlynx, prompting several analyst downgrades.

Biotech Stocks Post Double-Digit Gains in Monday Surge

Biotech stocks soared Monday amid takeover speculation and a slew of positive drug research test results.

Breaking News

Ford Makes a Major Change

The legacy automaker has just made a decision that will affect consumers buying its electric vehicles via a lease.

Tesla Q2 Deliveries Slump To 254,695 As Shanghai Shutdown, Supply Chain Snarls Take Toll

Tesla said it had a record rate of production in June, but supply chain disruption and the closure of its Shanghai gigafactory triggered a slump in Q2 deliveries.

Summers, Others Cite Growing Chance of Recession

GDP shrank an annualized 1.6% in the first quarter, and some experts anticipate another drop in the second quarter.

Coinbase Faces A New Scandal

The platform denies selling proprietary customer data and announces it is expanding into several European countries.